Q2 2026 saw modest revenue growth but a 16% drop in net income due to higher medical costs, increased operating expenses, and a significant accrual for Medicare Advantage risk adjustment. Medical membership declined 1.5% year-over-year, while operating cash flow improved.Original document: Elevance…
Q2 2026 saw modest revenue growth but a 16% drop in net income due to higher medical costs, increased operating expenses, and a significant accrual for Medicare Advantage risk adjustment. Medical membership declined 1.5% year-over-year, while operating cash flow improved.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
